e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Improving asthma therapy - new findings in established and experimental treatment modalities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Omalizumab and Churg-Strauss syndrome
A. M. Ruppert, D. Stanciu, G. Averous, S. Riehm, C. Debry, F. De Blay (Strasbourg, France)
Source:
Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Session:
Improving asthma therapy - new findings in established and experimental treatment modalities
Session type:
Thematic Poster Session
Number:
3641
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. M. Ruppert, D. Stanciu, G. Averous, S. Riehm, C. Debry, F. De Blay (Strasbourg, France). Omalizumab and Churg-Strauss syndrome. Eur Respir J 2007; 30: Suppl. 51, 3641
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
An intergrated approach to Churg-Strauss syndrome
Source: Annual Congress 2009 - Update on eosinophilic lung diseases
Year: 2009
Churg-Strauss's syndrome and eosinophilic polyserositis
Source: Eur Respir J 2002; 20: Suppl. 38, 65s
Year: 2002
Good tolerance of aspirin in Churg-Strauss syndrome
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
The basis of Churg-Strauss syndrome diagnosis in own material
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010
Airway and systemic inflammation during Churg-Strauss syndrome natural course
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012
Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69
Year: 2005
Anca and anti-gbm-antibodies in pulmonary-renal syndrome due to Wegener‘s granulomatosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?
Source: Eur Respir J 2015; 46: 1255-1258
Year: 2015
Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
Source: ERJ Open Res, 6 (4) 00339-2020; 10.1183/23120541.00339-2020
Year: 2020
Long-term follow-up in Churg-Strauss syndrome following IFN-α-induced remission
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Pulmonary involvement in antisynthetase syndrome: more than myopathy
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Heart involvement in Churg-Strauss syndrome (CSS)
Source: Eur Respir J 2006; 28: Suppl. 50, 384s
Year: 2006
Etanercept-induced pleuropericardial lupus-like syndrome
Source: Eur Respir J 2009; 33: 939-941
Year: 2009
BOOP as presenting manifestation of idiopathic hyper-eosinophilic syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 375s
Year: 2005
Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Source: Eur Respir J 2008; 32: 244-245
Year: 2008
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020
New therapy for pulmonary-renal Goodpasture‘s syndrome
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Severe persistent asthma in children with Ehlers-Danlos’ syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004
Successive treatment of Churg-Strauss syndrome with cyclesonide after oral steroids discontinuation due to side effects
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept